Novartis melanoma drug combination wins EU green light

ReutersNovartis melanoma drug combination wins EU green lightReutersLONDON European regulators on Friday recommended the use of a combination of Novartis's drugs Tafinlar and Mekinist for treating certain patients with melanoma, boosting prospects for medicines acquired from GlaxoSmithKline. The Swiss drugmaker ...and more »